189 related articles for article (PubMed ID: 24983362)
1. Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study.
Rojas Llimpe FL; Di Fabio F; Ercolani G; Giampalma E; Cappelli A; Serra C; Castellucci P; D'Errico A; Golfieri R; Pinna AD; Pinto C
Br J Cancer; 2014 Aug; 111(4):667-73. PubMed ID: 24983362
[TBL] [Abstract][Full Text] [Related]
2. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A
Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495
[TBL] [Abstract][Full Text] [Related]
3. Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis.
Tsili AC; Alexiou G; Naka C; Argyropoulou MI
Acta Radiol; 2021 Mar; 62(3):302-312. PubMed ID: 32506935
[TBL] [Abstract][Full Text] [Related]
4. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.
Lubezky N; Metser U; Geva R; Nakache R; Shmueli E; Klausner JM; Even-Sapir E; Figer A; Ben-Haim M
J Gastrointest Surg; 2007 Apr; 11(4):472-8. PubMed ID: 17436132
[TBL] [Abstract][Full Text] [Related]
5. Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.
Metser U; Halankar J; Langer D; Mohan R; Hussey D; Hadas M; Tamir S
Ann Nucl Med; 2017 Feb; 31(2):153-162. PubMed ID: 27848159
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.
Niekel MC; Bipat S; Stoker J
Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases.
Glazer ES; Beaty K; Abdalla EK; Vauthey JN; Curley SA
Arch Surg; 2010 Apr; 145(4):340-5; discussion 345. PubMed ID: 20404283
[TBL] [Abstract][Full Text] [Related]
8. PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.
Goshen E; Davidson T; Zwas ST; Aderka D
Technol Cancer Res Treat; 2006 Feb; 5(1):37-43. PubMed ID: 16417400
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Bharadwaz A; Tønner Nielsen D; Viborg Mortensen F; Morre Pedersen E
Eur Radiol; 2018 Nov; 28(11):4735-4747. PubMed ID: 29736846
[TBL] [Abstract][Full Text] [Related]
10. Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?
Ramos E; Valls C; Martinez L; Lladó L; Torras J; Ruiz S; Gamez C; Serrano T; Fabregat J; Rafecas A
Ann Surg Oncol; 2011 Sep; 18(9):2654-61. PubMed ID: 21431987
[TBL] [Abstract][Full Text] [Related]
11. Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?
Adie S; Yip C; Chu F; Morris DL
ANZ J Surg; 2009 May; 79(5):358-61. PubMed ID: 19566517
[TBL] [Abstract][Full Text] [Related]
12. Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT.
Bacigalupo L; Aufort S; Eberlé MC; Assenat E; Ychou M; Gallix B
Radiol Med; 2010 Oct; 115(7):1087-100. PubMed ID: 20574703
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy affects staging of colorectal liver metastasis--a comparison of PET, CT and intraoperative ultrasound.
Spatz J; Holl G; Sciuk J; Anthuber M; Arnholdt HM; Märkl B
Int J Colorectal Dis; 2011 Feb; 26(2):165-71. PubMed ID: 20960208
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of the FDG-PET/CT in patients with resected mucinous colorectal liver metastases.
Borello A; Russolillo N; Lo Tesoriere R; Langella S; Guerra M; Ferrero A
Surgeon; 2021 Oct; 19(5):e140-e145. PubMed ID: 34581274
[TBL] [Abstract][Full Text] [Related]
16. Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
Viganò L; Lopci E; Costa G; Rodari M; Poretti D; Pedicini V; Solbiati L; Chiti A; Torzilli G
Ann Surg Oncol; 2017 Apr; 24(4):1029-1036. PubMed ID: 27807727
[TBL] [Abstract][Full Text] [Related]
17. Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases.
Revheim ME; Haugvik SP; Johnsrud K; Mathisen Ø; Fjeld JG; Skretting A
Acta Radiol; 2015 Apr; 56(4):397-403. PubMed ID: 24682406
[TBL] [Abstract][Full Text] [Related]
18. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
19. Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT.
Kaltenbach TE; Graeter T; Mason RA; Kratzer W; Oeztuerk S; Haenle MM; Gruener B; Gottstein M
Nuklearmedizin; 2015; 54(1):43-9. PubMed ID: 25423884
[TBL] [Abstract][Full Text] [Related]
20. Role of PET/CT in the detection of liver metastases from colorectal cancer.
Orlacchio A; Schillaci O; Fusco N; Broccoli P; Maurici M; Yamgoue M; Danieli R; D'Urso S; Simonetti G
Radiol Med; 2009 Jun; 114(4):571-85. PubMed ID: 19444590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
